ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Diffusion MRI reveals amyloid plaque-associated cellular signatures through spatial transcriptomic integration.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionAmyloid plaque deposition is a defining feature of Alzheimer's disease (AD), yet how plaque-associated cellular alterations are reflected in noninvasive imaging remains unclear.
methodsWe integrated high-resolution diffusion magnetic resonance imaging (dMRI) with spatial transcriptomics (ST) in an AD mouse model. Spatial correlations were assessed across the whole brain and in disease-control and plaque-non-plaque comparisons. Neural network models were trained to predict AD-associated cell types from dMRI metrics.
resultsdMRI metrics showed moderate spatial correlations (r = -0.41 to 0.36) with oligodendrocyte- and neuron-related gene expression. Disease-control comparisons revealed region-specific MRI-derived microstructural alterations aligned with transcriptional changes in microglia, astrocytes, oligodendrocytes, and neurons. Plaque-rich regions exhibited distinct diffusion and susceptibility signatures associated with oligodendrocyte and microglial expression. Neural networks predicted spatial distributions of AD-associated cell types with 80%-86% accuracy. DISCUSSION: dMRI captures plaque-associated cellular pathology and supports biologically informed interpretation of imaging contrasts in AD.
Indexed as
Identifiers
42851120What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.